These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 7938213)
1. Biodistribution and PDT efficacy of a ketochlorin photosensitizer as a function of the delivery vehicle. Woodburn K; Chang CK; Lee S; Henderson B; Kessel D Photochem Photobiol; 1994 Aug; 60(2):154-9. PubMed ID: 7938213 [TBL] [Abstract][Full Text] [Related]
2. Interactions of Solutol HS 15 and Cremophor EL with plasma lipoproteins. Woodburn K; Sykes E; Kessel D Int J Biochem Cell Biol; 1995 Jul; 27(7):693-9. PubMed ID: 7648425 [TBL] [Abstract][Full Text] [Related]
3. Modulation of biodistribution, pharmacokinetics, and photosensitivity with the delivery vehicle of a bacteriochlorin photosensitizer for photodynamic therapy. Saavedra R; Rocha LB; Dąbrowski JM; Arnaut LG ChemMedChem; 2014 Feb; 9(2):390-8. PubMed ID: 24376035 [TBL] [Abstract][Full Text] [Related]
4. Biodistribution and virus inactivation efficacy of a silicon phthalocyanine in red blood cell concentrates as a function of delivery vehicle. Ben-Hur E; Zuk MM; Chin S; Banerjee D; Kenney ME; Horowitz B Photochem Photobiol; 1995 Sep; 62(3):575-9. PubMed ID: 8570715 [TBL] [Abstract][Full Text] [Related]
5. Effects of ursodeoxycholic acid on photodynamic therapy in a murine tumor model. Garbo GM; Vicente MG; Fingar V; Kessel D Photochem Photobiol; 2003 Oct; 78(4):407-10. PubMed ID: 14626670 [TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrin. Woodburn KW; Fan Q; Kessel D; Luo Y; Young SW J Invest Dermatol; 1998 May; 110(5):746-51. PubMed ID: 9579539 [TBL] [Abstract][Full Text] [Related]
7. Delivery of benzoporphyrin derivative, a photosensitizer, into atherosclerotic plaque of Watanabe heritable hyperlipidemic rabbits and balloon-injured New Zealand rabbits. Allison BA; Crespo MT; Jain AK; Richter AM; Hsiang YN; Levy JG Photochem Photobiol; 1997 May; 65(5):877-83. PubMed ID: 9155261 [TBL] [Abstract][Full Text] [Related]
8. Effect of delivery system on the pharmacokinetics and tissue distribution of bis(di-isobutyl octadecylsiloxy)silicon 2,3-naphthalocyanine (isoBOSINC), a photosensitizer for tumor therapy. Zuk MM; Rihter BD; Kenney ME; Rodgers MA; Kreimer-Birnbaum M Photochem Photobiol; 1996 Jan; 63(1):132-40. PubMed ID: 8577866 [TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growth. Ichikawa K; Takeuchi Y; Yonezawa S; Hikita T; Kurohane K; Namba Y; Oku N Cancer Lett; 2004 Mar; 205(1):39-48. PubMed ID: 15036659 [TBL] [Abstract][Full Text] [Related]
10. Pretreatment photosensitizer dosimetry reduces variation in tumor response. Zhou X; Pogue BW; Chen B; Demidenko E; Joshi R; Hoopes J; Hasan T Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1211-20. PubMed ID: 16504761 [TBL] [Abstract][Full Text] [Related]
11. The alteration of plasma lipoproteins by cremophor EL. Woodburn K; Kessel D J Photochem Photobiol B; 1994 Mar; 22(3):197-201. PubMed ID: 8014752 [TBL] [Abstract][Full Text] [Related]
12. Blood flow dynamics after photodynamic therapy with verteporfin in the RIF-1 tumor. Chen B; Pogue BW; Goodwin IA; O'Hara JA; Wilmot CM; Hutchins JE; Hoopes PJ; Hasan T Radiat Res; 2003 Oct; 160(4):452-9. PubMed ID: 12968929 [TBL] [Abstract][Full Text] [Related]
13. A next-generation bifunctional photosensitizer with improved water-solubility for photodynamic therapy and diagnosis. Nishie H; Kataoka H; Yano S; Kikuchi JI; Hayashi N; Narumi A; Nomoto A; Kubota E; Joh T Oncotarget; 2016 Nov; 7(45):74259-74268. PubMed ID: 27708235 [TBL] [Abstract][Full Text] [Related]
14. Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy. Chen B; Pogue BW; Hoopes PJ; Hasan T Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1216-26. PubMed ID: 15752904 [TBL] [Abstract][Full Text] [Related]
16. Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy. Vrouenraets MB; Visser GW; Loup C; Meunier B; Stigter M; Oppelaar H; Stewart FA; Snow GB; van Dongen GA Int J Cancer; 2000 Oct; 88(1):108-14. PubMed ID: 10962447 [TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy targeted to tumor-induced angiogenic vessels. Kurohane K; Tominaga A; Sato K; North JR; Namba Y; Oku N Cancer Lett; 2001 Jun; 167(1):49-56. PubMed ID: 11323098 [TBL] [Abstract][Full Text] [Related]
18. In vivo photosensitizing efficiency of a diphenylchlorin sensitizer: interest of a DMPC liposome formulation. Bourré L; Thibaut S; Fimiani M; Ferrand Y; Simonneaux G; Patrice T Pharmacol Res; 2003 Mar; 47(3):253-61. PubMed ID: 12591021 [TBL] [Abstract][Full Text] [Related]
19. Correlation of photosensitizer delivery to lipoproteins and efficacy in tumor and arthritis mouse models; comparison of lipid-based and Pluronic P123 formulations. Chowdhary RK; Sharif I; Chansarkar N; Dolphin D; Ratkay L; Delaney S; Meadows H J Pharm Pharm Sci; 2003; 6(2):198-204. PubMed ID: 12935430 [TBL] [Abstract][Full Text] [Related]
20. Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model. Richter AM; Waterfield E; Jain AK; Canaan AJ; Allison BA; Levy JG Photochem Photobiol; 1993 Jun; 57(6):1000-6. PubMed ID: 8367528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]